Chongqing Jiheng pharmaceutical. 

¥3.36
0
-¥0.04-1.18% 07:03 今天

統計

當日最高
3.47
當日最低
3.32
52週高點
6.24
52週低點
3.18
成交量
14,387,900
平均成交量
36,863,640
市值
2.3B
本益比
-
股息殖利率
-
股息
-

股息

0%股息殖利率
2020年7月
¥0.04
2019年8月
¥0.10
2018年5月
¥0.07
2017年5月
¥0.15
2016年5月
¥0.25
10年成長
不適用
5年成長
不適用
3年成長
不適用
1年成長
不適用

財務

-48.43%利潤率
未盈利
2020
2021
2022
2023
2024
2025
866.49M營收
-419.68M淨利

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Chongqing Sansheng Industrial Co.,Ltd. is a Chinese enterprise specializing in the research, development, production, and sale of a diverse range of products, spanning both building materials and chemicals, as well as pharmaceuticals. Within its building materials and chemical segment, the company supplies essential construction inputs such as commercial concrete, water-reducing agents, and expansion agents. These products find extensive application across various large-scale infrastructure projects, including industrial and residential buildings, highways, railways, bridges, tunnels, airports, and water conservancy facilities. Additionally, Sansheng Industrial manufactures sulfuric acid, a key chemical component vital for the production of chemical fertilizers, general industrial chemicals, light industry products, textiles, steel, and water reducer formulations, among other non-fertilizer acidic compounds. The company also maintains a significant presence in the pharmaceutical sector. Its offerings here encompass pharmaceutical intermediates, exemplified by procaine hydrochloride, cefoxitin intermediate, chloramphenicol intermediate, aztreonam intermediate, and orlistat intermediate, which are crucial precursors for antibiotic drugs, anti-hepatitis C treatments, diabetes medications, specific penicillin variants, and cosmetic formulations. Furthermore, Sansheng produces active pharmaceutical ingredients (APIs) such as acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benoate, and diphenhydramine hydrochloride. Its range of finished pharmaceutical preparations includes compound paracetamol diphenhydramine, clarithromycin sustained-release, diclofenac sodium enteric-coated, and famotidine tablets, designed for diverse therapeutic applications like antipyretic and analgesic effects, antiviral, antibacterial, cough relief, allergy management, and local anesthesia. Beyond these, the company provides a selection of clinically significant drugs, including famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, and norfloxacin. Established in 2002, the company was initially known as Chongqing Sansheng Special Building Materials Co., Ltd. before officially adopting its current name, Chongqing Sansheng Industrial Co.,Ltd., in October 2016. Its operations are headquartered in Chongqing, China.
顯示更多
執行長
Zhi Qiang Zhang
員工
979
國家
中國
ISIN
CNE100001WZ4

上市

0 則留言

分享你的想法

常見問題

Chongqing Jiheng pharmaceutical. 今天的股價是多少?▼
002742.SZ 目前價格為 ¥3.36 CNY,過去 24 小時下跌了 -1.18%。在圖表上更密切關注 Chongqing Jiheng pharmaceutical. 股票的表現。
Chongqing Jiheng pharmaceutical. 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Shenzhen Stock Exchange 交易所,Chongqing Jiheng pharmaceutical. 的股票以代號 002742.SZ 進行交易。
Chongqing Jiheng pharmaceutical. 的股價在上漲嗎?▼
002742.SZ 股票較上週下跌 -2.61%,本月下跌 -19.23%,過去一年 Chongqing Jiheng pharmaceutical. 下跌 -31.57%。
Chongqing Jiheng pharmaceutical. 的市值是多少?▼
今天 Chongqing Jiheng pharmaceutical. 的市值為 2.3B
Chongqing Jiheng pharmaceutical. 去年的營收是多少?▼
Chongqing Jiheng pharmaceutical. 去年的營收為 866.49MCNY。
Chongqing Jiheng pharmaceutical. 去年的淨利是多少?▼
002742.SZ 去年的淨收益為 -419.68MCNY。
Chongqing Jiheng pharmaceutical. 會發放股息嗎?▼
是的,002742.SZ 的股息每 年度 發放一次。每股最新股息為 0.04 。截至今日,股息殖利率(FWD)% 為 0%。
Chongqing Jiheng pharmaceutical. 有多少名員工?▼
截至 2026年11月3日,公司共有 979 名員工。
Chongqing Jiheng pharmaceutical. 位於哪個產業?▼
Chongqing Jiheng pharmaceutical.從事於Health & Wellness產業。
Chongqing Jiheng pharmaceutical. 何時完成拆股?▼
Chongqing Jiheng pharmaceutical. 上次拆股發生於 2017年9月8日,比例為 1:1。
Chongqing Jiheng pharmaceutical. 的總部在哪裡?▼
Chongqing Jiheng pharmaceutical. 的總部位於 中國 的 Chongqing。